nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—SLCO1B3—Docetaxel—skin cancer	0.281	0.39	CbGbCtD
Fexofenadine—ABCB1—Vismodegib—skin cancer	0.173	0.24	CbGbCtD
Fexofenadine—CYP2D6—Vemurafenib—skin cancer	0.129	0.179	CbGbCtD
Fexofenadine—ABCB1—Dactinomycin—skin cancer	0.0908	0.126	CbGbCtD
Fexofenadine—ABCB1—Docetaxel—skin cancer	0.0469	0.0651	CbGbCtD
Fexofenadine—Pain in extremity—Vismodegib—skin cancer	0.00623	0.0223	CcSEcCtD
Fexofenadine—Otitis media—Imiquimod—skin cancer	0.00581	0.0208	CcSEcCtD
Fexofenadine—Viral infection—Imiquimod—skin cancer	0.00501	0.0179	CcSEcCtD
Fexofenadine—Atrial fibrillation—Vemurafenib—skin cancer	0.00406	0.0145	CcSEcCtD
Fexofenadine—Pain in extremity—Vemurafenib—skin cancer	0.00385	0.0138	CcSEcCtD
Fexofenadine—Chest tightness—Docetaxel—skin cancer	0.00385	0.0138	CcSEcCtD
Fexofenadine—Back pain—Vismodegib—skin cancer	0.00363	0.013	CcSEcCtD
Fexofenadine—Injury—Imiquimod—skin cancer	0.00357	0.0128	CcSEcCtD
Fexofenadine—Otitis media—Temozolomide—skin cancer	0.00348	0.0125	CcSEcCtD
Fexofenadine—Atrial fibrillation—Imiquimod—skin cancer	0.00347	0.0124	CcSEcCtD
Fexofenadine—Pain in extremity—Imiquimod—skin cancer	0.00328	0.0118	CcSEcCtD
Fexofenadine—Myalgia—Vismodegib—skin cancer	0.0032	0.0114	CcSEcCtD
Fexofenadine—Viral infection—Temozolomide—skin cancer	0.003	0.0107	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00279	0.00999	CcSEcCtD
Fexofenadine—Dyspepsia—Vismodegib—skin cancer	0.0027	0.00965	CcSEcCtD
Fexofenadine—Fatigue—Vismodegib—skin cancer	0.00264	0.00945	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00264	0.00944	CcSEcCtD
Fexofenadine—Pain—Vismodegib—skin cancer	0.00262	0.00938	CcSEcCtD
Fexofenadine—Injury—Bleomycin—skin cancer	0.00254	0.00909	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vismodegib—skin cancer	0.00251	0.00897	CcSEcCtD
Fexofenadine—Dry eye—Temozolomide—skin cancer	0.0025	0.00896	CcSEcCtD
Fexofenadine—Abdominal pain—Vismodegib—skin cancer	0.00242	0.00867	CcSEcCtD
Fexofenadine—Sinusitis—Imiquimod—skin cancer	0.00237	0.0085	CcSEcCtD
Fexofenadine—Otitis media—Docetaxel—skin cancer	0.00232	0.00829	CcSEcCtD
Fexofenadine—Ear pain—Temozolomide—skin cancer	0.00231	0.00826	CcSEcCtD
Fexofenadine—Back pain—Vemurafenib—skin cancer	0.00224	0.00803	CcSEcCtD
Fexofenadine—Rhinorrhoea—Docetaxel—skin cancer	0.00223	0.00797	CcSEcCtD
Fexofenadine—Asthenia—Vismodegib—skin cancer	0.0022	0.00787	CcSEcCtD
Fexofenadine—Pruritus—Vismodegib—skin cancer	0.00217	0.00776	CcSEcCtD
Fexofenadine—Flushing—Imiquimod—skin cancer	0.00211	0.00755	CcSEcCtD
Fexofenadine—Diarrhoea—Vismodegib—skin cancer	0.0021	0.0075	CcSEcCtD
Fexofenadine—Thirst—Temozolomide—skin cancer	0.00207	0.0074	CcSEcCtD
Fexofenadine—Chest discomfort—Docetaxel—skin cancer	0.00204	0.00729	CcSEcCtD
Fexofenadine—Cough—Vemurafenib—skin cancer	0.00202	0.00724	CcSEcCtD
Fexofenadine—Myalgia—Vemurafenib—skin cancer	0.00197	0.00707	CcSEcCtD
Fexofenadine—Vomiting—Vismodegib—skin cancer	0.00195	0.00697	CcSEcCtD
Fexofenadine—Rash—Vismodegib—skin cancer	0.00193	0.00691	CcSEcCtD
Fexofenadine—Dermatitis—Vismodegib—skin cancer	0.00193	0.00691	CcSEcCtD
Fexofenadine—Back pain—Imiquimod—skin cancer	0.00191	0.00685	CcSEcCtD
Fexofenadine—Anaphylactic shock—Vemurafenib—skin cancer	0.00189	0.00677	CcSEcCtD
Fexofenadine—Infection—Vemurafenib—skin cancer	0.00188	0.00673	CcSEcCtD
Fexofenadine—Nausea—Vismodegib—skin cancer	0.00182	0.00651	CcSEcCtD
Fexofenadine—Agitation—Imiquimod—skin cancer	0.00182	0.00651	CcSEcCtD
Fexofenadine—Angioedema—Imiquimod—skin cancer	0.00181	0.00647	CcSEcCtD
Fexofenadine—Palpitations—Imiquimod—skin cancer	0.00175	0.00626	CcSEcCtD
Fexofenadine—Cough—Imiquimod—skin cancer	0.00173	0.00618	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00172	0.00617	CcSEcCtD
Fexofenadine—Myalgia—Imiquimod—skin cancer	0.00168	0.00603	CcSEcCtD
Fexofenadine—Dry mouth—Imiquimod—skin cancer	0.00165	0.00589	CcSEcCtD
Fexofenadine—Fatigue—Vemurafenib—skin cancer	0.00163	0.00584	CcSEcCtD
Fexofenadine—Nasopharyngitis—Fluorouracil—skin cancer	0.00162	0.0058	CcSEcCtD
Fexofenadine—Infection—Imiquimod—skin cancer	0.0016	0.00574	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Temozolomide—skin cancer	0.00158	0.00566	CcSEcCtD
Fexofenadine—Tachycardia—Imiquimod—skin cancer	0.00158	0.00564	CcSEcCtD
Fexofenadine—Pollakiuria—Temozolomide—skin cancer	0.00157	0.00562	CcSEcCtD
Fexofenadine—Flushing—Bleomycin—skin cancer	0.0015	0.00536	CcSEcCtD
Fexofenadine—Body temperature increased—Vemurafenib—skin cancer	0.0015	0.00536	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00147	0.00526	CcSEcCtD
Fexofenadine—Insomnia—Imiquimod—skin cancer	0.00146	0.00523	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00146	0.00521	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Docetaxel—skin cancer	0.00144	0.00517	CcSEcCtD
Fexofenadine—Dyspnoea—Imiquimod—skin cancer	0.00144	0.00515	CcSEcCtD
Fexofenadine—Somnolence—Imiquimod—skin cancer	0.00144	0.00514	CcSEcCtD
Fexofenadine—Sinusitis—Temozolomide—skin cancer	0.00142	0.00509	CcSEcCtD
Fexofenadine—Dyspepsia—Imiquimod—skin cancer	0.00142	0.00509	CcSEcCtD
Fexofenadine—Flushing—Dactinomycin—skin cancer	0.0014	0.005	CcSEcCtD
Fexofenadine—Hypersensitivity—Vemurafenib—skin cancer	0.00139	0.00499	CcSEcCtD
Fexofenadine—Fatigue—Imiquimod—skin cancer	0.00139	0.00498	CcSEcCtD
Fexofenadine—Atrial fibrillation—Docetaxel—skin cancer	0.00138	0.00494	CcSEcCtD
Fexofenadine—Pain—Imiquimod—skin cancer	0.00138	0.00494	CcSEcCtD
Fexofenadine—Asthenia—Vemurafenib—skin cancer	0.00136	0.00486	CcSEcCtD
Fexofenadine—Pruritus—Vemurafenib—skin cancer	0.00134	0.00479	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Imiquimod—skin cancer	0.00132	0.00472	CcSEcCtD
Fexofenadine—Epistaxis—Fluorouracil—skin cancer	0.00132	0.00472	CcSEcCtD
Fexofenadine—Sinusitis—Fluorouracil—skin cancer	0.00131	0.00469	CcSEcCtD
Fexofenadine—Pain in extremity—Docetaxel—skin cancer	0.00131	0.00468	CcSEcCtD
Fexofenadine—Diarrhoea—Vemurafenib—skin cancer	0.0013	0.00464	CcSEcCtD
Fexofenadine—Urticaria—Imiquimod—skin cancer	0.00128	0.00459	CcSEcCtD
Fexofenadine—Abdominal pain—Imiquimod—skin cancer	0.00128	0.00457	CcSEcCtD
Fexofenadine—Body temperature increased—Imiquimod—skin cancer	0.00128	0.00457	CcSEcCtD
Fexofenadine—Flushing—Temozolomide—skin cancer	0.00126	0.00452	CcSEcCtD
Fexofenadine—Dizziness—Vemurafenib—skin cancer	0.00125	0.00448	CcSEcCtD
Fexofenadine—Cough—Bleomycin—skin cancer	0.00123	0.00439	CcSEcCtD
Fexofenadine—Vomiting—Vemurafenib—skin cancer	0.0012	0.00431	CcSEcCtD
Fexofenadine—Myalgia—Bleomycin—skin cancer	0.0012	0.00428	CcSEcCtD
Fexofenadine—Rash—Vemurafenib—skin cancer	0.00119	0.00427	CcSEcCtD
Fexofenadine—Dermatitis—Vemurafenib—skin cancer	0.00119	0.00427	CcSEcCtD
Fexofenadine—Hypersensitivity—Imiquimod—skin cancer	0.00119	0.00426	CcSEcCtD
Fexofenadine—Headache—Vemurafenib—skin cancer	0.00119	0.00424	CcSEcCtD
Fexofenadine—Nasopharyngitis—Docetaxel—skin cancer	0.00117	0.00419	CcSEcCtD
Fexofenadine—Asthenia—Imiquimod—skin cancer	0.00116	0.00415	CcSEcCtD
Fexofenadine—Anaphylactic shock—Bleomycin—skin cancer	0.00115	0.0041	CcSEcCtD
Fexofenadine—Back pain—Temozolomide—skin cancer	0.00115	0.0041	CcSEcCtD
Fexofenadine—Pruritus—Imiquimod—skin cancer	0.00114	0.00409	CcSEcCtD
Fexofenadine—Infection—Bleomycin—skin cancer	0.00114	0.00408	CcSEcCtD
Fexofenadine—Nausea—Vemurafenib—skin cancer	0.00112	0.00402	CcSEcCtD
Fexofenadine—Vision blurred—Temozolomide—skin cancer	0.00112	0.004	CcSEcCtD
Fexofenadine—Myalgia—Dactinomycin—skin cancer	0.00112	0.00399	CcSEcCtD
Fexofenadine—Diarrhoea—Imiquimod—skin cancer	0.0011	0.00395	CcSEcCtD
Fexofenadine—Agitation—Temozolomide—skin cancer	0.00109	0.0039	CcSEcCtD
Fexofenadine—Angioedema—Temozolomide—skin cancer	0.00108	0.00388	CcSEcCtD
Fexofenadine—Dizziness—Imiquimod—skin cancer	0.00107	0.00382	CcSEcCtD
Fexofenadine—Infection—Dactinomycin—skin cancer	0.00106	0.0038	CcSEcCtD
Fexofenadine—Palpitations—Temozolomide—skin cancer	0.00105	0.00375	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00104	0.00374	CcSEcCtD
Fexofenadine—Cough—Temozolomide—skin cancer	0.00103	0.0037	CcSEcCtD
Fexofenadine—Vision blurred—Fluorouracil—skin cancer	0.00103	0.00368	CcSEcCtD
Fexofenadine—Vomiting—Imiquimod—skin cancer	0.00103	0.00367	CcSEcCtD
Fexofenadine—Dyspnoea—Bleomycin—skin cancer	0.00102	0.00366	CcSEcCtD
Fexofenadine—Rash—Imiquimod—skin cancer	0.00102	0.00364	CcSEcCtD
Fexofenadine—Dermatitis—Imiquimod—skin cancer	0.00102	0.00364	CcSEcCtD
Fexofenadine—Headache—Imiquimod—skin cancer	0.00101	0.00362	CcSEcCtD
Fexofenadine—Myalgia—Temozolomide—skin cancer	0.00101	0.00361	CcSEcCtD
Fexofenadine—Dry mouth—Temozolomide—skin cancer	0.000987	0.00353	CcSEcCtD
Fexofenadine—Pain—Bleomycin—skin cancer	0.000981	0.00351	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000974	0.00349	CcSEcCtD
Fexofenadine—Anaphylactic shock—Temozolomide—skin cancer	0.000967	0.00346	CcSEcCtD
Fexofenadine—Infection—Temozolomide—skin cancer	0.000961	0.00344	CcSEcCtD
Fexofenadine—Nausea—Imiquimod—skin cancer	0.000959	0.00343	CcSEcCtD
Fexofenadine—Epistaxis—Docetaxel—skin cancer	0.000951	0.00341	CcSEcCtD
Fexofenadine—Myalgia—Fluorouracil—skin cancer	0.00093	0.00333	CcSEcCtD
Fexofenadine—Fatigue—Dactinomycin—skin cancer	0.000922	0.0033	CcSEcCtD
Fexofenadine—Pain—Dactinomycin—skin cancer	0.000915	0.00327	CcSEcCtD
Fexofenadine—Urticaria—Bleomycin—skin cancer	0.000911	0.00326	CcSEcCtD
Fexofenadine—Body temperature increased—Bleomycin—skin cancer	0.000907	0.00324	CcSEcCtD
Fexofenadine—Anaphylactic shock—Fluorouracil—skin cancer	0.000891	0.00319	CcSEcCtD
Fexofenadine—Infection—Fluorouracil—skin cancer	0.000885	0.00317	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000881	0.00315	CcSEcCtD
Fexofenadine—Insomnia—Temozolomide—skin cancer	0.000875	0.00313	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000875	0.00313	CcSEcCtD
Fexofenadine—Tachycardia—Fluorouracil—skin cancer	0.00087	0.00311	CcSEcCtD
Fexofenadine—Dyspnoea—Temozolomide—skin cancer	0.000862	0.00309	CcSEcCtD
Fexofenadine—Somnolence—Temozolomide—skin cancer	0.00086	0.00308	CcSEcCtD
Fexofenadine—Dyspepsia—Temozolomide—skin cancer	0.000852	0.00305	CcSEcCtD
Fexofenadine—Abdominal pain—Dactinomycin—skin cancer	0.000845	0.00303	CcSEcCtD
Fexofenadine—Body temperature increased—Dactinomycin—skin cancer	0.000845	0.00303	CcSEcCtD
Fexofenadine—Hypersensitivity—Bleomycin—skin cancer	0.000845	0.00302	CcSEcCtD
Fexofenadine—Flushing—Docetaxel—skin cancer	0.00084	0.00301	CcSEcCtD
Fexofenadine—Fatigue—Temozolomide—skin cancer	0.000834	0.00299	CcSEcCtD
Fexofenadine—Pain—Temozolomide—skin cancer	0.000827	0.00296	CcSEcCtD
Fexofenadine—Asthenia—Bleomycin—skin cancer	0.000823	0.00294	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000812	0.00291	CcSEcCtD
Fexofenadine—Pruritus—Bleomycin—skin cancer	0.000811	0.0029	CcSEcCtD
Fexofenadine—Insomnia—Fluorouracil—skin cancer	0.000806	0.00289	CcSEcCtD
Fexofenadine—Dyspnoea—Fluorouracil—skin cancer	0.000795	0.00284	CcSEcCtD
Fexofenadine—Somnolence—Fluorouracil—skin cancer	0.000792	0.00284	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Temozolomide—skin cancer	0.000791	0.00283	CcSEcCtD
Fexofenadine—Hypersensitivity—Dactinomycin—skin cancer	0.000788	0.00282	CcSEcCtD
Fexofenadine—Dyspepsia—Fluorouracil—skin cancer	0.000785	0.00281	CcSEcCtD
Fexofenadine—Urticaria—Temozolomide—skin cancer	0.000768	0.00275	CcSEcCtD
Fexofenadine—Asthenia—Dactinomycin—skin cancer	0.000767	0.00275	CcSEcCtD
Fexofenadine—Body temperature increased—Temozolomide—skin cancer	0.000765	0.00274	CcSEcCtD
Fexofenadine—Abdominal pain—Temozolomide—skin cancer	0.000765	0.00274	CcSEcCtD
Fexofenadine—Back pain—Docetaxel—skin cancer	0.000762	0.00273	CcSEcCtD
Fexofenadine—Pain—Fluorouracil—skin cancer	0.000762	0.00273	CcSEcCtD
Fexofenadine—Diarrhoea—Dactinomycin—skin cancer	0.000732	0.00262	CcSEcCtD
Fexofenadine—Vomiting—Bleomycin—skin cancer	0.000729	0.00261	CcSEcCtD
Fexofenadine—Rash—Bleomycin—skin cancer	0.000723	0.00259	CcSEcCtD
Fexofenadine—Dermatitis—Bleomycin—skin cancer	0.000722	0.00259	CcSEcCtD
Fexofenadine—Hypersensitivity—Temozolomide—skin cancer	0.000713	0.00255	CcSEcCtD
Fexofenadine—Urticaria—Fluorouracil—skin cancer	0.000708	0.00253	CcSEcCtD
Fexofenadine—Body temperature increased—Fluorouracil—skin cancer	0.000705	0.00252	CcSEcCtD
Fexofenadine—Palpitations—Docetaxel—skin cancer	0.000697	0.00249	CcSEcCtD
Fexofenadine—Asthenia—Temozolomide—skin cancer	0.000694	0.00248	CcSEcCtD
Fexofenadine—Cough—Docetaxel—skin cancer	0.000688	0.00246	CcSEcCtD
Fexofenadine—Pruritus—Temozolomide—skin cancer	0.000684	0.00245	CcSEcCtD
Fexofenadine—Nausea—Bleomycin—skin cancer	0.000681	0.00244	CcSEcCtD
Fexofenadine—Vomiting—Dactinomycin—skin cancer	0.00068	0.00243	CcSEcCtD
Fexofenadine—Rash—Dactinomycin—skin cancer	0.000674	0.00241	CcSEcCtD
Fexofenadine—Myalgia—Docetaxel—skin cancer	0.000671	0.0024	CcSEcCtD
Fexofenadine—Diarrhoea—Temozolomide—skin cancer	0.000662	0.00237	CcSEcCtD
Fexofenadine—Hypersensitivity—Fluorouracil—skin cancer	0.000657	0.00235	CcSEcCtD
Fexofenadine—Dry mouth—Docetaxel—skin cancer	0.000656	0.00235	CcSEcCtD
Fexofenadine—Anaphylactic shock—Docetaxel—skin cancer	0.000643	0.0023	CcSEcCtD
Fexofenadine—Dizziness—Temozolomide—skin cancer	0.00064	0.00229	CcSEcCtD
Fexofenadine—Infection—Docetaxel—skin cancer	0.000639	0.00229	CcSEcCtD
Fexofenadine—Nausea—Dactinomycin—skin cancer	0.000635	0.00227	CcSEcCtD
Fexofenadine—Pruritus—Fluorouracil—skin cancer	0.000631	0.00226	CcSEcCtD
Fexofenadine—Tachycardia—Docetaxel—skin cancer	0.000628	0.00225	CcSEcCtD
Fexofenadine—Vomiting—Temozolomide—skin cancer	0.000615	0.0022	CcSEcCtD
Fexofenadine—Rash—Temozolomide—skin cancer	0.00061	0.00218	CcSEcCtD
Fexofenadine—Diarrhoea—Fluorouracil—skin cancer	0.00061	0.00218	CcSEcCtD
Fexofenadine—Dermatitis—Temozolomide—skin cancer	0.000609	0.00218	CcSEcCtD
Fexofenadine—Headache—Temozolomide—skin cancer	0.000606	0.00217	CcSEcCtD
Fexofenadine—Dizziness—Fluorouracil—skin cancer	0.000589	0.00211	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000586	0.0021	CcSEcCtD
Fexofenadine—Insomnia—Docetaxel—skin cancer	0.000582	0.00208	CcSEcCtD
Fexofenadine—Nausea—Temozolomide—skin cancer	0.000575	0.00206	CcSEcCtD
Fexofenadine—Dyspnoea—Docetaxel—skin cancer	0.000574	0.00205	CcSEcCtD
Fexofenadine—Somnolence—Docetaxel—skin cancer	0.000572	0.00205	CcSEcCtD
Fexofenadine—Vomiting—Fluorouracil—skin cancer	0.000567	0.00203	CcSEcCtD
Fexofenadine—Dyspepsia—Docetaxel—skin cancer	0.000566	0.00203	CcSEcCtD
Fexofenadine—Rash—Fluorouracil—skin cancer	0.000562	0.00201	CcSEcCtD
Fexofenadine—Dermatitis—Fluorouracil—skin cancer	0.000561	0.00201	CcSEcCtD
Fexofenadine—Headache—Fluorouracil—skin cancer	0.000558	0.002	CcSEcCtD
Fexofenadine—Fatigue—Docetaxel—skin cancer	0.000555	0.00199	CcSEcCtD
Fexofenadine—Pain—Docetaxel—skin cancer	0.00055	0.00197	CcSEcCtD
Fexofenadine—Nausea—Fluorouracil—skin cancer	0.000529	0.00189	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Docetaxel—skin cancer	0.000526	0.00188	CcSEcCtD
Fexofenadine—Abdominal pain—Docetaxel—skin cancer	0.000509	0.00182	CcSEcCtD
Fexofenadine—Body temperature increased—Docetaxel—skin cancer	0.000509	0.00182	CcSEcCtD
Fexofenadine—Hypersensitivity—Docetaxel—skin cancer	0.000474	0.0017	CcSEcCtD
Fexofenadine—Asthenia—Docetaxel—skin cancer	0.000462	0.00165	CcSEcCtD
Fexofenadine—Pruritus—Docetaxel—skin cancer	0.000455	0.00163	CcSEcCtD
Fexofenadine—Diarrhoea—Docetaxel—skin cancer	0.00044	0.00158	CcSEcCtD
Fexofenadine—Dizziness—Docetaxel—skin cancer	0.000425	0.00152	CcSEcCtD
Fexofenadine—Vomiting—Docetaxel—skin cancer	0.000409	0.00146	CcSEcCtD
Fexofenadine—Rash—Docetaxel—skin cancer	0.000406	0.00145	CcSEcCtD
Fexofenadine—Dermatitis—Docetaxel—skin cancer	0.000405	0.00145	CcSEcCtD
Fexofenadine—Headache—Docetaxel—skin cancer	0.000403	0.00144	CcSEcCtD
Fexofenadine—Nausea—Docetaxel—skin cancer	0.000382	0.00137	CcSEcCtD
